Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
NAYA Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q2 2025 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q3 2025 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q4 2025 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
NAYA Biosciences, Inc. Earnings Date And Information
NAYA Biosciences, Inc. last posted its earnings results on Tuesday, April 22nd, 2025. The company reported $-3.5 earnings per share for the quarter, topping analysts' consensus estimates of $-42.00002 by $38.50002. The company had revenue of 1.43 M for the quarter and had revenue of 3.02 M for the year. NAYA Biosciences, Inc. has generated $-5 earnings per share over the last year ($-5.1308 diluted earnings per share) and currently has a price-to-earnings ratio of -1.14. NAYA Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based on prior year's report dates.
NAYA Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | N/A | -$0.42 | N/A | $4.04 M | $1.43 M |
| 06/30/2024 | Q2 2024 | N/A | -$0.62 | N/A | $3.27 M | $1.84 M |
| 03/31/2024 | Q1 2024 | N/A | -$0.42 | N/A | N/A | $1.58 M |
| 12/31/2023 | Q4 2023 | -$10.44 | -$0.80 | 9.64 | N/A | $1.38 M |
| 09/30/2023 | Q3 2023 | -$11.88 | -$0.70 | 11.18 | $997.11 K | $974.89 K |
| 06/29/2023 | Q2 2023 | N/A | -$1.53 | N/A | $450.00 K | $315.90 K |
| 03/30/2023 | Q1 2023 | N/A | -$2.05 | N/A | N/A | $348.03 K |
| 12/30/2022 | Q4 2022 | N/A | -$2.27 | N/A | N/A | $278.14 K |
| 09/29/2022 | Q3 2022 | N/A | -$2.10 | N/A | N/A | $235.32 K |
| 06/29/2022 | Q2 2022 | N/A | -$2.31 | N/A | N/A | $146.14 K |
| 03/30/2022 | Q1 2022 | N/A | -$2.30 | N/A | N/A | $162.60 K |
| 12/30/2021 | Q4 2021 | N/A | -$0.12 | N/A | N/A | $3.05 M |
| 09/29/2021 | Q3 2021 | N/A | -$2.14 | N/A | N/A | $218.87 K |
| 06/29/2021 | Q2 2021 | N/A | -$1.74 | N/A | N/A | $208.47 K |
| 03/30/2021 | Q1 2021 | N/A | -$2.48 | N/A | N/A | $684.52 K |
| 12/30/2020 | Q4 2020 | N/A | -$6.00 | N/A | N/A | $196.57 K |
| 09/29/2020 | Q3 2020 | N/A | -$5.73 | N/A | N/A | $336.07 K |
| 06/29/2020 | Q2 2020 | N/A | -$2.68 | N/A | N/A | $246.07 K |
| 03/30/2020 | Q1 2020 | N/A | -$2.94 | N/A | N/A | $258.57 K |
| 12/30/2019 | Q4 2019 | N/A | -$1.55 | N/A | N/A | $328.57 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NAYA Biosciences, Inc. Earnings: FAQ's
NAYA Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based offlast year's report dates.
In the previous quarter, NAYA Biosciences, Inc. (:NAYA) reported $-3.5 earnings per share (EPS) to beat the analysts' consensus estimate of $-42.00002 by $38.50002.
The conference call for NAYA Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for NAYA Biosciences, Inc.'s latest earnings report can be read online.
NAYA Biosciences, Inc. (:NAYA) has a recorded annual revenue of $3.02 M.
NAYA Biosciences, Inc. (:NAYA) has a recorded net income of $-8,034,612.NAYA Biosciences, Inc. has generated $-5.1308 earnings per share over the last four quarters.
NAYA Biosciences, Inc. (:NAYA) has a price-to-earnings ratio of -1.14 and price/earnings-to-growth ratio is -0.1.